Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure

被引:0
作者
Simini, Giulia [1 ]
Akor, Frances [1 ]
Szydlo, Richard [1 ]
Laffan, Michael [1 ,2 ]
Arachchillage, Deepa R. J. [1 ,2 ,3 ]
机构
[1] Imperial Coll Healthcare NHS Trust, Dept Haematol, London, England
[2] Imperial Coll London, Ctr Haematol, Dept Immunol & Inflammat, London, England
[3] Hammersmith Hosp, Imperial Coll, Ctr Haematol, Dept Immunol & Inflammat, 5th Floor,Commonwealth Bldg,Du Cane Rd,London W12, London W12 0NN, England
关键词
MOLECULAR-WEIGHT HEPARIN; HEMORRHAGIC COMPLICATIONS; STANDARD HEPARIN; DEFINITION; MANAGEMENT;
D O I
10.1055/s-0043-1772706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:298 / 302
页数:5
相关论文
共 28 条
  • [1] DISAPPEARANCE OF CIRCULATING ANTI-XA ACTIVITY AFTER INTRAVENOUS-INJECTION OF STANDARD HEPARIN AND OF A LOW-MOLECULAR WEIGHT HEPARIN (CY-216) IN NORMAL AND NEPHRECTOMIZED RABBITS
    CARANOBE, C
    BARRET, A
    GABAIG, AM
    DUPOUY, D
    SIE, P
    BONEU, B
    [J]. THROMBOSIS RESEARCH, 1985, 40 (01) : 129 - 133
  • [2] Effect of Pulmonary Rehabilitation for Patients With Post-COVID-19: A Systematic Review and Meta-Analysis
    Chen, Huan
    Shi, Hangyu
    Liu, Xitong
    Sun, Tianheng
    Wu, Jiani
    Liu, Zhishun
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [3] An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score
    Chopard, Romain
    Piazza, Gregory
    Falvo, Nicolas
    Ecarnot, Fiona
    Besutti, Mathieu
    Capellier, Gilles
    Schiele, Francois
    Badoz, Marc
    Meneveau, Nicolas
    [J]. CHEST, 2021, 160 (05) : 1832 - 1843
  • [4] DESWART CAM, 1984, BLOOD, V63, P836
  • [5] FOLLEA G, 1986, HAEMOSTASIS, V16, P147
  • [6] Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes
    Gaertner, Sebastien
    Cordeanu, Elena-Mihaela
    Nouri, Salah
    Faller, Alix-Marie
    Frantz, Anne-Sophie
    Mirea, Corina
    Bilbault, Pascal
    Ohlmann, Patrick
    Le Ray, Isabelle
    Stephan, Dominique
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 226 : 103 - 109
  • [7] Anticoagulant use in patients with chronic renal impairment
    Grand'Maison A.
    Charest A.F.
    Geerts W.H.
    [J]. American Journal of Cardiovascular Drugs, 2005, 5 (5) : 291 - 305
  • [8] Characterizing the Safety Profile of Apixaban Versus Warfarin in Moderate to Severe Chronic Kidney Disease at a Veterans Affairs Hospital
    Herndon, Kyle
    Guidry, Tommie Jo
    Wassell, Katelyn
    Elliott, Whitney
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (06) : 554 - 560
  • [9] Mechanism of action and pharmacology of unfractionated heparin
    Hirsh, J
    Anand, SS
    Halperin, JL
    Fuster, V
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (07) : 1094 - 1096
  • [10] Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis
    Hylek, EM
    Regan, S
    Henault, LE
    Gardner, M
    Chan, AT
    Singer, DE
    Barry, MJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) : 621 - 627